Recanaclotide

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRecanaclotide
Drug Alias NameIW-9179
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGuanylate cyclase stimulants
TargetsGuanylate cyclase
Therapy Area/IndicationsDiabetic GastroparesisDyspepsiaGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIronwood Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetic GastroparesisDyspepsiaGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A